PLSE · NASDAQ
Pulse Biosciences (PLSE) Stock Price & Fundamentals
Pulse Biosciences (PLSE) closed at $264.61 on Oct 9, 2026, up 0.38% from the previous close of $263.61.
Share price, past year
1Y −5.75%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $264.61 |
| Sep 30, 2026 | $271.41 |
| Aug 31, 2026 | $260.43 |
| Jul 31, 2026 | $266.42 |
| Jun 30, 2026 | $256.48 |
| May 29, 2026 | $260.55 |
| Apr 30, 2026 | $261.01 |
| Mar 31, 2026 | $267.15 |
| Feb 27, 2026 | $269.21 |
| Jan 30, 2026 | $273.98 |
| Dec 31, 2025 | $280.71 |
| Nov 28, 2025 | $286.08 |
| Oct 31, 2025 | $283.81 |
Key statistics
- Market cap
- $18.73B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $1.19M
- Net income (TTM)
- −$80.06M
- Shares outstanding
- 70.8M
- Dividend yield
- —
- 52-week range
- $253.05 – $289.61
Pulse Biosciences's market cap is $18.73B, based on a share price of $264.61 and 70.8M shares outstanding as of Jun 30, 2026.
Financials
Pulse Biosciences reported revenue of $350.00K for fiscal 2025.
Pulse Biosciences reported a net loss of $72.78M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $350.00K | — | −$72.78M | −20,794.6% | — | −$54.44M |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$53.59M | — | — | −$36.47M |
| FY2023ended Dec 31, 2023 | $0.00 | −100.0% | −$42.21M | — | — | −$33.16M |
| FY2022ended Dec 31, 2022 | $700.00K | −50.6% | −$58.51M | −8,357.9% | — | −$47.41M |
| FY2021ended Dec 31, 2021 | $1.42M | — | −$63.66M | −4,489.4% | −$2.28 | −$54.53M |
| FY2020ended Dec 31, 2020 | $0.00 | — | −$49.85M | — | −$2.14 | −$35.81M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $434.00K | −$24.66M | — |
| Q1 FY2026ended Mar 31, 2026 | $401.00K | −$18.58M | — |
| Q4 FY2025ended Dec 31, 2025 | $264.00K | −$17.43M | — |
| Q3 FY2025ended Sep 30, 2025 | $86.00K | −$19.39M | — |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$19.17M | — |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$16.80M | — |
| Q4 FY2024ended Dec 31, 2024 | $0.00 | −$19.39M | — |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$12.68M | — |
Company profile
- Name
- Pulse Biosciences, Inc
- Ticker
- PLSE
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 3957 Point Eden Way, Hayward, CA 94545
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001625101
Recent SEC filings
- Oct 7, 2026
- Sep 15, 2026
- Sep 15, 2026
- Aug 6, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 29, 2026
- Jun 12, 2026
Frequently asked questions
What is Pulse Biosciences's stock price?
Pulse Biosciences (PLSE) closed at $264.61 on Oct 9, 2026, up 0.38% from the previous close of $263.61.
What is Pulse Biosciences's market cap?
Pulse Biosciences's market cap is $18.73B, based on a share price of $264.61 and 70.8M shares outstanding as of Jun 30, 2026.
How much revenue does Pulse Biosciences make?
Pulse Biosciences reported revenue of $350.00K for fiscal 2025.
Does Pulse Biosciences pay a dividend?
Pulse Biosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Pulse Biosciences, Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures